Hira Malik, registration number 2083134, was issued a 12-month warning by the General Pharmaceutical Council (GPhC) after giving a patient with anorexia nervosa weight loss drugs.
At a hearing on August 11, the GPhC’s investigating committee said the pharmacist and independent prescriber was the superintendent for a pharmacy that gave “six supplies of Mounjaro” to the anorexia patient but this was “inappropriate and unsafe”.
According to the hearing document, Malik was the prescriber “for five of those supplies” of Mounjaro and she was given “falsified information by the patient”.
But she “did not make sufficient or adequate checks to ensure its accuracy when she should have done so”.
Read more: Inside the online pharmacy growing weight loss scripts by the thousands
The committee said Malik was the superintendent of one online pharmacy and the sole trader proprietor of another. The GPhC register names her as superintendent of Oushk Pharmacy Ltd, while her LinkedIn says she was previously superintendent of Curate Health.
Malik had spoken with the GPhC and been “reminded on numerous occasions” since 2023 of the “standards and guidance for providing pharmacy services at a distance, including when the guidance was updated in February 2025”.
Malik was a prescriber for both pharmacies, which both prescribed and dispensed weight loss medicines and failed inspections in 2024 and 2025.
Read more: Two pharmacies face MHRA action over weight loss ads
One pharmacy was given an “improvement action plan” and the other an “improvement notice” but after one was reinspected, it failed to meet the GPhC’s standards for a second time and was given a “further improvement action plan”.
The committee said that pharmacy did not independently verify patients’ weight and height, obtain “enough reliable information about patients’ health and medicines”, and prescribing decisions records were “inadequate”.
The pharmacy also “relied on a patient’s self-declaration” of whether they had an “ongoing or past history of an eating disorder” and information on treatment and supplies were “not shared with patients’ GPs”.
Read more: Mum landed in hospital after taking Facebook ad Mounjaro
The committee noted that Malik made a “number of changes to her practice in the intervening period”.
But she was warned about ensuring the pharmacy has “all the information required to ensure that supplies are clinically appropriate” and “proper safeguards are in place to safeguard patients” before prescribing and dispensing weight loss medicines.
“Inappropriate supplies and lack of safeguards put public safety at risk and can undermine confidence in the profession,” the hearing document said.
Read more: GPhC ‘looking into’ two online pharmacies after influencer concerns
The committee said Malik breached two standards where pharmacy professionals “must work in partnership with others” and “must use their professional judgement”.
It added that “any repetition of this or similar conduct” would likely result in “further regulatory intervention”.
Read the determination in full here.
